EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary

Published:2009-04 Issue:6 Volume:45 Page:931-991
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sant Milena,Allemani Claudia,Santaquilani Mariano,Knijn Arnold,Marchesi Francesca,Capocaccia Riccardo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. Survival of cancer patients in Europe: the EUROCARE Study: IARC Scientific Publications No. 132;Berrino,1995

2. Survival of cancer patients in Europe: the EUROCARE-2 Study: IARC Scientific Publications No. 151;Berrino,1999

3. Survival of cancer patients in Europe: the EUROCARE-3 Study;Berrino;Ann Oncol,2003

4. EUROCARE Working group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study;Berrino;Lancet Oncol,2007

5. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data;Verdecchia;Lancet Oncol,2007

Cited by 702 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Preliminary Study of a Prototype Cryoablation Needle on Porcine Livers for Pancreatic Cancer Treatment;Journal of Clinical Medicine;2024-08-23

2. Exploring the prognostic value of circular RNAs in pancreatic ductal adenocarcinoma using genome-wide expression profiling;Pancreatology;2024-08

3. The diagnostic capability of i-scan for early gastric cancer detection: a systematic review and meta-analysis;Minerva Gastroenterology;2024-06

4. Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019;eClinicalMedicine;2024-05

5. ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3